Page last updated: 2024-10-29

amrinone and Aortic Valve Stenosis

amrinone has been researched along with Aortic Valve Stenosis in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Aortic Valve Stenosis: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Whitten, CW1
Latson, TW1
Klein, KW1
Elmore, J1
Spencer, R1
Duggar, P1

Reviews

1 review available for amrinone and Aortic Valve Stenosis

ArticleYear
Anesthetic management of a hypothyroid cardiac surgical patient.
    Journal of cardiothoracic and vascular anesthesia, 1991, Volume: 5, Issue:2

    Topics: Amrinone; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Intravenous; Aortic Valve; Aortic

1991